Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance

doi:10.3748/wjg.v20.i30.10338

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 30

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8526)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

598

WORD

225

HTML

5027

Figures (1-3)

223

Tables (1-3)

196

Sum=6269

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1199

Download

1058

Sum=2257

Aug 14, 2014 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (58)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 14, 2014; 20(30): 10338-10347
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10338

Full Size Figure Download Figure

Figure 1 Intention-to-treat cure rates of concomitant therapy over the last three years in studies conducted in Latin America, Asia and Europe, broken down by the duration of therapy. Studies with Intention-to-treat (ITT) < 85% are grey marked.

Citation: Molina-Infante J, Gisbert JP. Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. World J Gastroenterol 2014; 20(30): 10338-10347
URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10338.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i30.10338